Tests an AI-made meal plan for taste changes caused by cancer chemotherapy
Tests an AI-based meal plan for taste changes in adults with cancer.
Plain-language title generated from the registry record
Registry title: Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
Key facts
- Where
- Munich, Regensburg, and Würzburg, GermanySee the 3 sites
Where in Germany
- LMU KlinikumMunich, GermanyNo longer taking part
- Universitätsklinikum RegensburgRegensburg, GermanyTaking people
- Universitätsklinikum WürzburgWürzburg, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wuerzburg University Hospital
- Trial code
- NCT07040189
- Record updated
- 21 August 2026
- Original description
The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This pilot study aims to use an AI-based, or rule-driven system to generate personalized recommendations based on patients' specific impairments and taste disorder. For the pilot study, the AI will be trained on recipes to create individualized meal plans, helping to identify foods that are likely to be better. The primary endpoint is the assessment of the nutritional intervention as helpful at the second visit within 12 weeks of inclusion.Read full original descriptionShow less
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This pilot study aims to use an AI-based, or rule-driven system to generate personalized recommendations based on patients' specific impairments and taste disorder. For the pilot study, the AI will be trained on recipes to create individualized meal plans, helping to identify foods that are likely to be better. The primary endpoint is the assessment of the nutritional intervention as helpful at the second visit within 12 weeks of inclusion.
Inclusion: Age ≥ 18; Suffering from one of the following tumor entities: Multiple myeloma or malignant tumor of the gastrointestinal tract; Mainly oral nutrition; Subjectively perceived tumor therapy-related taste disorder; At least two clinical presentations planned within 12 weeks with a minimum interval of three weeks; Ability to participate in nutritional intervention, including use of the online portal and implementation of recipe suggestions (e.g. resources and access to a kitchen), either independently or with third-party support (e.g. by relatives, outpatient care services).
Exclusion: Taste disorder explained by other causes (e.g. existing before therapy or COVID disease); Pregnancy; Placement in an inpatient care facility.